Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 5/20 | 0.65 |
| ▸ | PPARA | Q07869 | 5/20 | 0.65 |
| ▸ | TERT | O14746 | 3/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.53 |
| ▸ | PPARD | Q03181 | 3/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.53 |
| ▸ | BLM | P54132 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | FABP4 | P15090 | 2/20 | 0.53 |
| ▸ | FAAH | O00519 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | TOP1 | P11387 | 2/20 | 0.53 |
| ▸ | GMNN | O75496 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4553754 | 1.00 | PPARG (0.65) | PPARGPPARATERTPTPN1PPARD | |
| SCHEMBL29469553 | 1.00 | PPARG (0.65) | PPARGPPARATERTPTPN1PPARD | |
| SCHEMBL7207656 | 1.00 | PPARG (0.65) | PPARGPPARATERTPTPN1PPARD | |
| SCHEMBL7207661 | 1.00 | PPARG (0.65) | PPARGPPARATERTPTPN1PPARD | |
| SCHEMBL3264779 | 0.98 | PPARG (0.61) | PPARGPPARATERTPTPN1PPARD | |
| SCHEMBL3264781 | 0.98 | PPARG (0.61) | PPARGPPARATERTPTPN1PPARD | |
| SCHEMBL5228105 | 0.91 | PPARG (0.53) | PPARGPPARATERTPTPN1PPARD | |
| SCHEMBL5228093 | 0.91 | PPARG (0.53) | PPARGPPARATERTPTPN1PPARD | |
| Nonanal SCHEMBL23241878 | 0.87 | TSHR (0.57) | PPARGPPARATERTPTPN1CYP1A2 | |
| Decanal SCHEMBL28843644 | 0.87 | TSHR (0.57) | PPARGPPARATERTPTPN1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8987486-B2 | Trans-2-decenoic acid derivative and pharmaceutical agent containing the same | NAGOYA INDUSTRIAL SCIENCE RESEARCH INSTITUTE (JP) | 2015-03-24 | — | — | US | disclosed |
| US-20130225837-A1 | TRANS-2-DECENOIC ACID DERIVATIVE AND PHARMACEUTICAL AGENT CONTAINING THE SAME | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 2013-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130225837-A1 | TRANS-2-DECENOIC ACID DERIVATIVE AND PHARMACEUTICAL AGENT CONTAINING THE SAME | BDNF, NTRK2, NGF | PPARG 1310/4885PPARA 1112/4885TERT 340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.